Paragon 28, Inc. (FNA)

USD 10.04

(-3.09%)

Operating Income Summary of Paragon 28, Inc.

  • Paragon 28, Inc.'s latest annual operating income in 2023 was -37.3 Million USD , down -6.45% from previous year.
  • Paragon 28, Inc.'s latest quarterly operating income in 2024 Q2 was -10.76 Million USD , up 16.55% from previous quarter.
  • Paragon 28, Inc. reported an annual operating income of -35.04 Million USD in 2022, down -225.26% from previous year.
  • Paragon 28, Inc. reported an annual operating income of -10.77 Million USD in 2021, down -291.49% from previous year.
  • Paragon 28, Inc. reported a quarterly operating income of -12.9 Million USD for 2024 Q1, down -14.9% from previous quarter.
  • Paragon 28, Inc. reported a quarterly operating income of -8.98 Million USD for 2023 Q3, up 4.04% from previous quarter.

Annual Operating Income Chart of Paragon 28, Inc. (2023 - 2019)

Historical Annual Operating Income of Paragon 28, Inc. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -37.3 Million USD -6.45%
2022 -35.04 Million USD -225.26%
2021 -10.77 Million USD -291.49%
2020 5.62 Million USD 107.18%
2019 2.71 Million USD 0.0%

Peer Operating Income Comparison of Paragon 28, Inc.

Name Operating Income Operating Income Difference
Abbott Laboratories 6.47 Billion USD 100.576%
Allurion Technologies Inc. -78.07 Million USD 52.216%
Artivion, Inc. 5.74 Million USD 749.756%
Avanos Medical, Inc. 4.2 Million USD 988.31%
Butterfly Network, Inc. -145.61 Million USD 74.377%
Butterfly Network, Inc. -145.61 Million USD 74.377%
Bio-Rad Laboratories, Inc. 383.79 Million USD 109.721%
Boston Scientific Corporation 2.34 Billion USD 101.592%
Perspective Therapeutics, Inc. -15.18 Million USD -145.745%
CONMED Corporation 130.78 Million USD 128.527%
Edwards Lifesciences Corporation 1.53 Billion USD 102.432%
Glaukos Corporation -128.7 Million USD 71.011%
Globus Medical, Inc. 133.14 Million USD 128.022%
Inspire Medical Systems, Inc. -40.27 Million USD 7.355%
Integer Holdings Corporation 167.33 Million USD 122.297%
Medtronic plc 5.14 Billion USD 100.725%
Nevro Corp. -99.3 Million USD 62.431%
Owlet, Inc. -28.63 Million USD -30.305%
Penumbra, Inc. 73.55 Million USD 150.725%
Vicarious Surgical Inc. -80.66 Million USD 53.749%
Smith & Nephew plc 425 Million USD 108.779%
Sonendo, Inc. -57.74 Million USD 35.388%
STERIS plc 836.11 Million USD 104.462%
Stryker Corporation 3.88 Billion USD 100.96%
Vapotherm, Inc. -39.08 Million USD 4.532%
Zimmer Biomet Holdings, Inc. 1.27 Billion USD 102.92%